Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Xellia Establishes New NA HQ | Contract Pharma

What are you searching for?

Sign in
Breaking News

Xellia Establishes New NA HQ

Expands Raleigh, NC site to move headquarters from Illinois

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Xellia Pharmaceuticals, a specialty pharmaceutical company providing anti-infective treatments, has expanded its Raleigh, NC site to enable the relocation of its North American headquarters from Grayslake, IL. One year removed from its acquisition of the Raleigh plant from Fresenius Kabi, Xellia has taken on new premises adjacent to its dedicated lyophilized (free-dried) vial manufacturing facility.

The result is the combination of the company’s North American commercial function with the manufacturing facility into one location, forming the new headquarters for the territory. Staff based at the Grayslake site have begun a phased relocation.

“The U.S. is a key market for Xellia and the expansion is part of our long-term growth strategy and commitment to manufacturing in the U.S., for our North American customers,” said Carl-Ake Carlsson, chief executive officer, Xellia. “Consolidating our state-of-the-art production facility with our commercial headquarters will enable us to better serve our many customers—both with respect to proximity and working relationship. We are building a stronger, more connected U.S. operation.”

Xellia has over 100 years of pharmaceutical industry experience and specializes in difficult-to-manufacture and develop anti-infective products. The company says it is increasingly moving on from its origins as a manufacturer of active pharmaceutical ingredients (APIs) to better serve its global customer base of over 500 pharmaceutical companies by supplying the finished dosage form (FDF) of its drugs.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics